These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27719972)

  • 1. [Diagnostic criteria. Benefits of early diagnosis].
    Gil Gregorio P
    Rev Esp Geriatr Gerontol; 2016 Jun; 51 Suppl 1():7-11. PubMed ID: 27719972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mild behavioral impairment: a new concept for the prodromic phases of dementia].
    Agüera Ortiz L; López Álvarez J
    Rev Esp Geriatr Gerontol; 2017 Jun; 52 Suppl 1():24-27. PubMed ID: 29628029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus.
    Arbizu J; García-Ribas G; Carrió I; Garrastachu P; Martínez-Lage P; Molinuevo JL
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):303-13. PubMed ID: 26099942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Map of Alzheimer's disease and other dementias in Spain. MapEA Project].
    Martínez-Lage P; Martín-Carrasco M; Arrieta E; Rodrigo J; Formiga F
    Rev Esp Geriatr Gerontol; 2018; 53(1):26-37. PubMed ID: 29107401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of vascular cognitive impairment and its main categories.
    Rodríguez García PL; Rodríguez García D
    Neurologia; 2015 May; 30(4):223-39. PubMed ID: 22739039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective cognitive impairment: Towards early identification of Alzheimer disease.
    Garcia-Ptacek S; Eriksdotter M; Jelic V; Porta-Etessam J; Kåreholt I; Manzano Palomo S
    Neurologia; 2016 Oct; 31(8):562-71. PubMed ID: 23601758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid.
    Monge Argilés JA; Blanco Cantó MA; Leiva Salinas C; Flors L; Muñoz Ruiz C; Sánchez Payá J; Gasparini Berenguer R; Leiva Santana C
    Neurologia; 2014 Sep; 29(7):397-401. PubMed ID: 23969296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Community Pharmacy in the Early Detection of Mild Cognitive Impairment. Warning Signs].
    Teresa Climent M; Molinero A
    Rev Esp Geriatr Gerontol; 2017 Jun; 52 Suppl 1():49-53. PubMed ID: 29628037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cost effectiveness of services for early diagnosis and intervention in dementia.
    Banerjee S; Wittenberg R
    Int J Geriatr Psychiatry; 2009 Jul; 24(7):748-54. PubMed ID: 19206079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Net economic costs of dementia in Canada.
    Ostbye T; Crosse E
    CMAJ; 1994 Nov; 151(10):1457-64. PubMed ID: 7954140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cognitive impairment in older adults: A systematic review for the U.S. Preventive Services Task Force.
    Lin JS; O'Connor E; Rossom RC; Perdue LA; Eckstrom E
    Ann Intern Med; 2013 Nov; 159(9):601-12. PubMed ID: 24145578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic impact of cognitive impairment and dementia].
    Cantarero Prieto D
    Rev Esp Geriatr Gerontol; 2017 Jun; 52 Suppl 1():58-60. PubMed ID: 29628039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of anticholinergic drugs on cognitive impairment in the elderly].
    López-Álvarez J; Zea Sevilla MA; Agüera Ortiz L; Fernández Blázquez MÁ; Valentí Soler M; Martínez-Martín P
    Rev Psiquiatr Salud Ment; 2015; 8(1):35-43. PubMed ID: 25087132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias.
    Hill J; Fillit H; Thomas SK; Chang S
    Pharmacoeconomics; 2006; 24(3):265-80. PubMed ID: 16519548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The worldwide societal costs of dementia: Estimates for 2009.
    Wimo A; Winblad B; Jönsson L
    Alzheimers Dement; 2010 Mar; 6(2):98-103. PubMed ID: 20298969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tractography of the uncinate fasciculus and the posterior cingulate fasciculus in patients with mild cognitive impairment and Alzheimer disease].
    Larroza A; Moratal D; D'ocón Alcañiz V; Arana E;
    Neurologia; 2014; 29(1):11-20. PubMed ID: 23582374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina.
    Allegri RF; Butman J; Arizaga RL; Machnicki G; Serrano C; Taragano FE; Sarasola D; Lon L
    Int Psychogeriatr; 2007 Aug; 19(4):705-18. PubMed ID: 16870037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic costs of dementia in Korea, 2002.
    Suh GH; Knapp M; Kang CJ
    Int J Geriatr Psychiatry; 2006 Aug; 21(8):722-8. PubMed ID: 16858741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation and adaptation of the Disability Assessment for Dementia scale in the Spanish population.
    Sánchez-Pérez A; López-Roig S; Pampliega Pérez A; Peral Gómez P; Pastor MÁ; Hurtado-Pomares M
    Med Clin (Barc); 2017 Sep; 149(6):248-252. PubMed ID: 28527600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis and progression of cognitive impairment. Preventive measures].
    López Mongil R; López Trigo JA
    Rev Esp Geriatr Gerontol; 2016 Jun; 51 Suppl 1():34-43. PubMed ID: 27719971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.